贝叶斯半参数元分析预测先验用于临床试验历史对照借用
该文提出一种贝叶斯半参数元分析预测先验,利用Dirichlet过程混合先验放宽参数假设,使模型自适应学习历史与当前对照数据的关系,并推广了先验有效样本量估计方法。通过模拟研究和强直性脊柱炎II期概念验证试验比较现有方法,表明该稳健化先验无需预先指定借用程度,能更灵活稳健地整合多来源历史数据。
要点
- 半参数元分析预测先验可自适应学习历史与当前对照数据关系,减少预先指定借用量的需求。
- Dirichlet过程混合先验放宽参数假设,增强对历史试验异质性或数据冲突的稳健性。
- 推广的先验有效样本量估计为借用信息量提供直观量化,便于针对任务调整先验。
核心结论
- 所提出的元分析预测先验稳健化方法无需预先指定借用程度,为临床试验设计与分析中整合多来源历史数据提供了更灵活稳健的途径。
研究设计与样本
- 方法学文章,提出贝叶斯半参数元分析预测先验,并通过广泛模拟研究和强直性脊柱炎II期概念验证试验比较现有方法性能。
主要发现
- Dirichlet过程混合先验允许放宽参数假设,使模型自适应学习历史与当前对照数据的关系。
- 推广了针对所提先验的有效样本量估计方法,可直观量化从历史试验借用的信息量。
- 模拟研究和强直性脊柱炎II期概念验证试验表明,所提方法相较于现有方法具有效果。
临床怎么用
- 在临床试验设计中,当需要借用历史对照信息时,可采用该半参数元分析预测先验,避免预先指定借用程度。
- 利用推广的有效样本量估计可直观评估借用信息量,并据此调整先验以适应具体任务。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
When designing a clinical trial, borrowing historical control information can provide a more efficient approach by reducing the necessary control arm sample size while still yielding increased power. Several Bayesian methods for incorporating historical information via a prior distribution have been proposed, for example, (modified) power prior, (robust) meta-analytic predictive prior. When utilizing historical control borrowing, the prior parameter(s) must be specified to determine the magnitude of borrowing before the current data are observed. Thus, a flexible prior is needed in case of heterogeneity between historic trials or prior data conflict with the current trial. To incorporate the ability to selectively borrow historic information, we propose a Bayesian semiparametric meta-analytic-predictive prior. Using a Dirichlet process mixture prior allows for relaxation of parametric assumptions, and lets the model adaptively learn the relationship between the historic and current control data. Additionally, we generalize a method for estimating the prior effective sample size (ESS) for the proposed prior. This gives an intuitive quantification of the amount of information borrowed from historical trials, and aids in tuning the prior to the specific task at hand. We illustrate the effectiveness of the proposed methodology by comparing performance between existing methods in an extensive simulation study and a phase II proof-of-concept trial in ankylosing spondylitis. In summary, our proposed robustification of the meta-analytic-predictive prior alleviates the need for prespecifying the amount of borrowing, providing a more flexible and robust method to integrate historical data from multiple study sources in the design and analysis of clinical trials.
引用
- Hupf B, Bunn V, Lin J, et al. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials. Stat Med. 2021. PMID: 33851441. doi:10.1002/sim.8970
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。